Equites Radar

OPCH · Option Care Health, Inc.

Medical Care FacilitiesUnited StatesAnalyst view: Hold

$31.22

-0.22% last session

End-of-day data · close of 2026-10-23

Mildly bullish3 bullish · 2 bearish technical signals
Consensus: Hold (3.00 from 8 analysts)
To mean target: -3.8%

Market cap

$5B

Enterprise value

$6B

Trailing P/E

23.7

Forward P/E

15.0

Dividend yield

0.0%

Beta

0.58

Avg volume

4M

Employees

8K

Daily Change %

-0.22%

5 Days Change

0.29%

10 Days Change

0.61%

30 Days Change

34.06%

60 Days Change

32.19%

Month to Day Change

38.57%

Year to Day Change

-1.79%

Analyst Outlook

Consensus ratingHold
Recommendation mean (1–5)3.00
Covering analysts8
Mean price target$30.03
Low price target$23.00
Upside to mean target-3.8%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)82.0
50-day MA$25.71
200-day MA$26.37
Price vs 50-day MA+21.4%
Price vs 200-day MA+18.4%
MACD histogram0.05
Volume vs 3-month avg0.7×
52w low $19.5252w high $36.59

Analyst sentiment over time — OPCH

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-10-09

Latest call per bank · past 12 months

UBS

Neutral

$32.05

+2.7% vs price
▼ cut from $39.00Downgrade · 2026-10-09

JP Morgan

Neutral

$33.00

+5.7% vs price
▲ raised from $0.00Downgrade · 2026-10-07

Jefferies

Hold

$32.05

+2.7% vs price
▲ raised from $28.00Downgrade · 2026-10-07

Deutsche Bank

Hold

$24.00

-23.1% vs price
▼ cut from $26.00Downgrade · 2026-07-30

Goldman Sachs

Neutral

$22.00

-29.5% vs price
▲ raised from $0.00Initiates · 2026-06-08

Morgan Stanley

Overweight

$485

+1453.5% vs price
▲ raised from $0.00Maintains · 2026-05-06

Bank of America

Buy

$35.00

+12.1% vs price
▲ raised from $32.00Maintains · 2025-12-09

Recent rating actions

DateFirmActionRatingPrice target
2026-10-09UBSDowngradeBuy → Neutral$39.00 → $32.05
2026-10-07William BlairDowngradeOutperform → Market Perform$0.00
2026-10-07JP MorganDowngradeOverweight → Neutral$0.00 → $33.00
2026-10-07CitizensDowngradeMarket Outperform → Market Perform$0.00
2026-10-07JefferiesDowngradeBuy → Hold$28.00 → $32.05
2026-10-07Barrington ResearchDowngradeOutperform → Market Perform$0.00
2026-07-30Deutsche BankDowngradeBuy → Hold$26.00 → $24.00
2026-07-17Stephens & Co.DowngradeOverweight → Equal-Weight$30.00 → $24.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-10-23

  • bearish: RSI (14): RSI is 82 — overbought territory; the recent run-up may be due for a pause.
  • bullish: Price vs 50-day MA: Trading 21.4% above the 50-day MA ($25.71).
  • bullish: Price vs 200-day MA: Trading 18.4% above the 200-day MA ($26.37).
  • bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • bullish: MACD (12,26,9): MACD histogram is positive (+0.05) — short-term momentum is improving.
  • neutral: 52-week range: Price sits between the 52-week low ($19.52) and high ($36.59).

OPCH Price Chart

Loading chart for OPCH…

Fundamentals

Revenue (TTM)$6.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$8.41
Net Debt / EBITDA2.6
WACC8.0%
Revenue growth2.00%
Earnings growth13.00%

About Option Care Health, Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

More in Medical Care Facilities

Screen OPCH against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.